NC

Nexthera Capital Portfolio holdings

AUM $120M
This Quarter Return
+8.92%
1 Year Return
+20.18%
3 Year Return
+117.79%
5 Year Return
10 Year Return
AUM
$284M
AUM Growth
+$284M
Cap. Flow
+$48.9M
Cap. Flow %
17.24%
Top 10 Hldgs %
63.96%
Holding
56
New
16
Increased
10
Reduced
3
Closed
18
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ANIP icon
26
ANI Pharmaceuticals
ANIP
$2.03B
$2.7M 0.5% +41,905 New +$2.7M
KALV icon
27
KalVista Pharmaceuticals
KALV
$678M
$1.76M 0.33% +180,794 New +$1.76M
LRMR icon
28
Larimar Therapeutics
LRMR
$310M
$792K 0.15% +171,435 New +$792K
TGTX icon
29
TG Therapeutics
TGTX
$4.65B
$246K 0.05% +30,000 New +$246K
VTGN icon
30
VistaGen Therapeutics
VTGN
$102M
$154K 0.03% 138,132
ARRY
31
DELISTED
Array Biopharma Inc
ARRY
-615,437 Closed -$7.57M
SPPI
32
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
0
SIOX
33
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
0
CLVS
34
DELISTED
Clovis Oncology, Inc.
CLVS
-184,680 Closed -$15.2M
ZSAN
35
DELISTED
Zosano Pharma Corporation
ZSAN
-375,809 Closed -$309K
FLXN
36
DELISTED
Flexion Therapeutics, Inc.
FLXN
-271,136 Closed -$6.56M
ALXN
37
DELISTED
Alexion Pharmaceuticals Inc
ALXN
-62,337 Closed -$8.75M
AVEO
38
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-52,000 Closed -$190K
ABEO icon
39
Abeona Therapeutics
ABEO
$350M
0
ACRS icon
40
Aclaris Therapeutics
ACRS
$209M
-416,312 Closed -$10.7M
AZN icon
41
AstraZeneca
AZN
$248B
0
BMY icon
42
Bristol-Myers Squibb
BMY
$96B
0
GSK icon
43
GSK
GSK
$79.9B
-358,053 Closed -$14.5M
INDP icon
44
Indaptus Therapeutics
INDP
$7.19M
-276,324 Closed -$2.47M
MDGL icon
45
Madrigal Pharmaceuticals
MDGL
$9.76B
-28,536 Closed -$1.28M
NERV icon
46
Minerva Neurosciences
NERV
$16.5M
-536,899 Closed -$4.08M
SUPN icon
47
Supernus Pharmaceuticals
SUPN
$2.53B
-132,270 Closed -$5.29M
TEVA icon
48
Teva Pharmaceuticals
TEVA
$21.1B
0
XBI icon
49
SPDR S&P Biotech ETF
XBI
$5.07B
0
SGEN
50
DELISTED
Seagen Inc. Common Stock
SGEN
-373,000 Closed -$20.3M